In vitro systems for tissue engineering

Annals of the New York Academy of Sciences

Volumn 961, Issue , 2002, Pages 10-26

  Godbey, W T ^a   Atala, A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Biomaterials; Bioreactors; Tissue engineering

Indexed keywords

BIOMATERIAL;

BIOREACTOR; CELL ENCAPSULATION; CELL FUNCTION; CONFERENCE PAPER; GENE TARGETING; HUMAN; IMPLANTATION; IN VITRO STUDY; NONHUMAN; TISSUE ENGINEERING;

EID: 0036291344     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb03041.x     Document Type: Conference Paper

References (110)

1. Renal homotransplantation in identical twins
2. Sessile macrophages forming clear endothelium-like membrane of successful keratoprosthesis
3. The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model
4. Twenty-year comparison of tissue and mechanical valve replacement
5. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells
6. Development of biocompatible synthetic extracellular matrices for tissue engineering
7. Mouse hepatocytes migrate to liver parenchyma and function idenfinitely after intrasplenic transplantatin
8. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation
9. Biocompatibility and degradatin mechanism of predegraded and non-degraded poly(lactide) implants: An animal study
10. Integrins: Versatility, modulation and signaling in cell adhesion
11. Growth factors
12. Synthesis and RGD peptide modification of a new biodegradable copolymer poly (lactic acid-co-lysine)
13. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial
14. Autologous cell transplantation for urologic reconstruction
15. Biologic biomaterials: Tissue-derived biomaterials (collagen)
16. Immunochemistry of collagens and procollagens
17. Collagen-based devices for soft tissue repair
18. Cell growth on collagen: A review of tissue engineering using scaffolds containing extracellular matrix
19. Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects
20. Design of an artificial skin. I. Basic design principles
21. Collagen fabrics as biomaterials
22. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux
23. Microencapsulated islets as bioartificial endocrine pancreas
24. Alginate as an immobilization matrix for cells
25. Bladder augmentation using allogenic bladder submucosa seeded with cells
26. Engineered vessels: Importance of the extracellular matrix
27. Engineered smooth muscle tissues: Regulating cell phenotype with the scaffold
28. Acellular collagen matrix as a possible "off the shelf" biomaterial for urethral repair
29. Biodegradable polymers
30. Biodegradable polymer scaffolds for tissue engineering
31. Preparation and characterization of poly(L-lactic acid) foams
32. Open pore biodegradable matrices formed with gas foaming
33. Synthesis and RGD peptide modification of a new biodegradable copolymer poly (lactic acid-co-lysine)
34. Glycine glycolic acid based copolymers
35. Copolymerization and degradation of poly (lactic acid-co-lysine)
36. New challenges in biomaterials
37. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro
38. Stem cells in tissue engineering applications for incontinence
39. Embryonic stem cells as a source for urologic tissue reconstruction
40. Effects of temperature on biodegradation characteristics of organic pollutants and microbial community in a solid phase aerobic bioreactor treating high strength organic wastewater
41. Nucleotide phylogenetic analysis of bacterial communities in mesophilic and thermophilic bioreactors treating pharmaceutical wastewater
42. Anaerobic dechlorination of perchloroethene in an extractive membrane bioreactor
43. Continuous wine making by delignified cellulosic materials supported biocatalyst: An attractive process for industrial applications
44. Immobilized salt-tolerant yeasts: Application of a new polyethylene-oxide support in a continuous stirred-tank reactor for flavour production
45. Optimization of hepatocyte spheroid formation for hepatic tissue engineering on three-dimensional biodegradable polymer within a flow bioreactor prior to implantation
46. Dynamic seeding and in vitro culture of hepatocytes in a flow perfusion system
47. Formation of spheroidal aggregates of hepatocytes on biodegradable polymers under continuous-flow bioreactor conditions
48. Bioreactor development for tissue-engineered cartilage
49. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves
50. Neural precursor cells form rudimentary tissue-like structures in a rotating-wall vessel bioreactor
51. Numerical model and experimental validation of microcarrier motion in a rotating bioreactor
52. Extracellular matrix specificity for the differentiation of capillary endothelial cells
53. The formation of fenestrations and channels by capillary endothelium in vitro
54. Cell therapy for erythropoietin (EPO) deficient anemias
55. Implantation of vascular grafts lined with genetically modified endothelial cells
56. High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors
57. Prospects for a bioartificial kidney
58. Development of a bioartificial renal tubule for the treatment of acute renal failure
59. Tissue engineering of a bioartificial tubule
60. Bioreactor perfusion system for the long-term maintenance of tissue-engineered skeletal muscle organoids
61. Hepatocyte attachment on biodegradable modified chitosan membranes: In vitro evaluation for the development of liver organoids
62. Highly porous polymer matrices as a three-dimensional culture system for hepatocytes
63. Concept for organ engineering: A reconstruction method of rat liver for in vitro culture
64. Improvement of Schwann cell attachment and proliferation on modified hyaluronic acid strands by polylysine
65. Preadipocyte seeded PLGA scaffolds for adipose tissue engineering
66. The growth and morphological behavior of salivary epithelial cells on matrix protein-coated biodegradable substrata
67. Functional human corneal equivalents constructed from cell lines
68. In vitro culture characteristics of corneal epithelial, endothelial, and keratocyte cells in a native collagen matrix
69. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10
70. Development of technologies aiding large-tissue engineering
71. Replacement of an avulsed phalanx with tissue-engineered bone
72. Cultured skin as a "smart material" for healing wounds: Experience in venous ulcers
73. Functional arteries grown in vitro
74. A completely biological tissue-engineered human blood vessel
75. De novo reconstitution of a functional urinary bladder by tissue engineering
76. Transplantation of islets using microencapsulation: Studies in diabetic rodents and dogs
77. Effects of micro-encapsulation on morphology and endocrine function of cryopreserved neonatal porcine islet-like cell clusters
78. Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation
79. Microencapsulation of human parathyroid cells: An "in vitro" study
80. Microencapsulation of Leydig cells: A new system for the therapeutic delivery of testosterone
81. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy
82. Dose control with cell lines used for encapsulated cell therapy
83. Recent progress in gene delivery using non-viral transfer complexes
84. Gene-based cancer vaccines: An ex vivo approach
85. High-efficiency non-viral transfection of primary chondrocytes and perichondrial cells for ex-vivo gene therapy to repair articular cartilage defects
86. The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells
87. Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates: Implication for ex vivo gene therapy
88. A novel gene delivery system using urothelial tissue engineered neo-organs
89. Direct-, fibroblast- and myoblast-mediated gene transfer to the anterior cruciate ligament
90. Ex vivo and in vivo gene transfer to the peritoneal membrane in a rat model
91. Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy
92. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain
93. Astrocyte line SVG-TH grafted in a rat model of Parkinson's disease
94. Approach to ex vivo gene therapy in the treatment of Parkinson's disease
95. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF
96. Human fetal astrocytes as an ex vivo gene therapy vehicle for delivering biologically active nerve growth factor
97. Growth of cultured mammalian cells on secondary glucose sources
98. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury
99. Beta cell culture on synthetic capillaries: An artificial endocrine pancreas
100. Insulin independence in a type 1 diabetic patient after encapsulated islets transplantation
101. Articular cartilage repair: Behavior of rabbit chondrocytes during tissue culture and subsequent allografting
102. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes
103. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation
104. Bioengineered corneas - The promise and the challenge
105. Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro
106. Bladder regeneration by tissue engineering